FMI
MIRM icon

F/M Investments’s Mirum Pharmaceuticals MIRM Stock Holding History

F/M Investments’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.03M Buy
51,483
+572
+1% +$57.4K 0.31% 68
2026
Q1 		$4.7M Sell
50,911
-2,177
-4% -$205K 0.31% 69
2025
Q4 		$4.19M Buy
53,088
+23,282
+78% +$1.67M 0.16% 161
2025
Q3 		$2.19M Buy
29,806
+1,250
+4% +$79.5K 0.08% 230
2025
Q2 		$1.45M Buy
+28,556
New +$1.27M 0.05% 274

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

F/M Investments's MIRM Position: Q2 2026 in Review

F/M Investments increased its Mirum Pharmaceuticals (MIRM) stake by 1.1% in Q2 2026, buying an estimated $57.4K and bringing the position to 51,483 shares worth $6.03M. The position accounts for 0.31% of the portfolio, ranked #68.

F/M Investments first reported a position in MIRM in Q2 2025 and has held it in 5 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • F/M Investments held 51,483 shares of Mirum Pharmaceuticals worth $6.03M as of Q2 2026.
  • F/M Investments bought 572 Mirum Pharmaceuticals shares in Q2 2026, an estimated $57.4K.
  • Mirum Pharmaceuticals made up 0.31% of F/M Investments's portfolio in Q2 2026, its #68 holding.
  • F/M Investments first reported a position in Mirum Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on F/M Investments's 13F filing for Q2 2026, filed 5 Aug 2026.